Efficacy Study of Early Versus Late Oseltamivir Administration for Treating and Preventing Influenza
Monitoring Influenza Severity on Tamiflu (MIST)
Sponsor: Centers for Disease Control and Prevention
Listed as NCT00555893, this NA trial focuses on Influenza and remains completed. Sponsored by Centers for Disease Control and Prevention, it has been updated 10 times since 2008, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Nov 2018 — Jan 2021 [monthly]
Completed NA
-
Oct 2018 — Nov 2018 [monthly]
Completed NA
-
Jun 2018 — Oct 2018 [monthly]
Completed NA
-
Feb 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Jan 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centers for Disease Control and Prevention
- Marshfield Clinic Research Foundation
For direct contact, visit the study record on ClinicalTrials.gov .